Category: WFN1 Contributors

12325710 / 2562 POSTS
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Expanding the Potential Indications for Hemopurifier Treatment Aethlon Medical’s (NASDAQ:AEMD) clinical trials are moving forward and expanding, as AEMD continues to demonstrate the effective ...
By Brad Sorensen, CFA NYSE:GNS READ THE FULL GNS RESEARCH REPORT Genius Group (NYSE:GNS) was founded by entrepreneur and best-selling author Roger James Hamilton and went public on the NYSE in April of 2022. Genius appears to be aiming to be a “one-s ...
By Beth Senko, CFA OTC:PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) continued on a steady path in 2Q FY22. Management’s confidence in the underlying business led to the decision to pay an additional cash dividend of $0.075/share ...
I know who the number one competitor is: yourself.  I’m not talking about that! This is about the competitor you can’t see, and yet is out there on every deal that you’re trying to get. The competitor you can’t see is ‘no ...
By Thomas Kerr, CFA NASDAQ:NNBR READ THE FULL NNBR RESEARCH REPORT NN, Inc. (NASDAQ:NNBR) is a diversified industrial company that combines complex materials science expertise with advanced engineering and production capabilities to design and manufa ...
By Steven Ralston, CFA OTC:BLSTF | ASX:BSX READ THE FULL BLSTF RESEARCH REPORT Blackstone Minerals (OTC:BLSTF) (ASX:BSX) is pursuing the development of the district-scale Ta Khoa Nickel Project through a vertically integrated strategy which entails a ...
By David Bautz, PhD NASDAQ:MDNA READ THE FULL MDNA RESEARCH REPORT Business Update Encouraging CD8+ T Cell and NK Cell Responses in ABILITY Trial On June 22, 2022, Medicenna Therapeutics Corp. (NASDAQ:MDNA) provided an update on the Phase 1/2 ABILITY ...
By David Bautz, PhD NASDAQ:BVXV READ THE FULL BVXV RESEARCH REPORT Business Update Significant Progress Made in NanoAbs Program On May 12, 2022, BiondVax (NASDAQ:BVXV) announced that Dr. Tamar Ben-Yedidia, the company’s Chief Scientific Officer, pres ...
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Filovirus Vaccine Candidate Exhibits 100% Protection in Non-Human Primates On June 24, 2022, Soligenix, Inc. (NASDAQ:SNGX) announced positive results from a study of a ...
By Beth Senko, CFA OTC:MITI READ THE FULL MITI RESEARCH REPORT Mitesco, Inc. (OTC:MITI) is building a better model for primary care. Headed by veteran physician practice clinical and business leaders, Mitesco’s “The Good Clinic” seeks to improve heal ...
12325710 / 2562 POSTS